Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
AstraZeneca's Covid-19 antibody cocktail misses the mark in preventing symptoms post-exposure
Endpoints
Tue, 06/15/21 - 10:45 am
AstraZeneca
monoclonal antibodies
AZD7442
COVID-19
clinical trials
Pfizer, AstraZeneca vaccines effective against delta variant, studies suggest
Beckers Hospital Review
Tue, 06/15/21 - 10:33 am
Pfizer
AstraZeneca
COVID-19
vaccines
Delta COVID-19 variant
EU Hits AstraZeneca Vaccine with Another Blood Condition for Side Effect List
BioSpace
Mon, 06/14/21 - 11:47 pm
AstraZeneca
COVID-19
vaccines
Europe
EMA
plasma leaks
In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment
Endpoints
Mon, 06/14/21 - 10:29 am
AstraZeneca
JNJ
AbbVie
clinical trials
CLL
Gazyva
Imbruvica
Venclexta
Study links AstraZeneca COVID-19 shot to bleeding disorder ITP
Pharmaforum
Thu, 06/10/21 - 11:00 am
AstraZeneca
vaccines
ITP
COVID-19
AstraZeneca takes PARP battle to court, seeking a larger claim to GSK's key cancer med Zejula: report
Fierce Pharma
Mon, 06/7/21 - 08:45 pm
GSK
Tesaro
AstraZeneca
legal
Zejula
Lynparza
AstraZeneca Redefining Cancer Care in Breast Cancer, Leukemia at ASCO
BioSpace
Mon, 06/7/21 - 08:41 pm
AstraZeneca
ASCO 2021
breast cancer
CLL
Lynparza
Calquence
Alexion, AstraZeneca executives switch roles amid $39B buyout
BioPharma Dive
Sun, 06/6/21 - 10:33 pm
AstraZeneca
Alexion
M&A
#ASCO21: AstraZeneca's PD-1 Imfinzi tacks on 5-year survival data in NSCLC, which it's calling 'unprecedented'
Endpoints
Fri, 06/4/21 - 10:48 am
ASCO 2021
AstraZeneca
non-small cell lung cancer
Imfinzi
An AstraZeneca, Merck drug slows the return of genetic breast cancer. Will testing speed up?
BioPharma Dive
Thu, 06/3/21 - 11:11 pm
ASCO 2021
AstraZeneca
Merck
breast cancer
genetic breast cancer
Lynparza
AstraZeneca in talks to produce COVID-19 vaccine for feds at Catalent site in Maryland: report
Fierce Pharma
Thu, 06/3/21 - 10:55 am
AstraZeneca
COVID-19
vaccines
Catalent
drug manufacturing
Japan authorizes AstraZeneca and Moderna’s Covid-19 vaccines
Pharmaceutical Business Review
Mon, 05/24/21 - 10:51 am
Japan
COVID-19
vaccines
AstraZeneca
Moderna Therapeutics
Pfizer and AstraZeneca COVID-19 vaccines are ‘highly effective’ against India variant
Biopharma Reporter
Mon, 05/24/21 - 10:40 am
vaccines
Pfizer
AstraZeneca
COVID-19
COVID-19 variants
Japan approves two more COVID vaccines as fourth infection wave hits
Pharmaforum
Fri, 05/21/21 - 10:45 am
Japan
COVID-19
vaccines
AstraZeneca
Moderna Therapeutics
ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca
BioSpace
Thu, 05/20/21 - 12:35 pm
ASCO 2021
Sanofi
Sloane Kettering
Incyte
AstraZeneca
Exelixis
oncology
ACC 2021: AstraZeneca's Farxiga failed to help COVID-19 patients, but it’s safe for them to use
Fierce Pharma
Sun, 05/16/21 - 11:22 pm
AstraZeneca
Farxiga
COVID-19
Blood clots linked to AstraZeneca's vaccine may be caused by its preservative, scientist says
Beckers Hospital Review
Sat, 05/15/21 - 10:53 pm
AstraZeneca
vaccines
COVID-19
blood clots
EDTA
Mixing Pfizer and AstraZeneca COVID-19 vaccines increases mild side effects but is safe, study shows
Marketwatch
Thu, 05/13/21 - 12:13 pm
COVID-19
vaccines
clinical trials
side effects
Pfizer
BioNTech
AstraZeneca
Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent
Fierce Biotech
Thu, 05/13/21 - 10:57 am
Amgen
AstraZeneca
tezepelumab
asthma
severe asthma
Sanofi
Dupixent
FDA
As data near, U.K. rethinks AstraZeneca COVID-19 antibody deal
Fierce Biotech
Wed, 05/12/21 - 10:49 am
AstraZeneca
UK
COVID-19
antibodies
AZD7442
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
…
next ›
last »